JDRF Funded Study Demonstrating Pancreatic Islet Xenograft Survival With Kamada’s AAT

glioblastoma-xenograft-model-nu0901-5-2col

Kamada Ltd. have announced that favorable results from a preclinical study analyzing the effects of the Company’s human Alpha-1 Antitrypsin (AAT), Glassia, in inter-species islet graft transplantation were published in PLOS One

Read more

Posted in Artificial Pancreas